Pharmanutra SpA is an Italian pharmaceutical company with a medium risk ESG score. Specializing in nutraceutical supplements and medical devices, Pharmanutra SpA is involved in research, design, development, and marketing. With products like SiderAL Folic, UltraMag, and Cetilar, the company serves markets in Europe, the Middle East, South America, Asia, and beyond.